Sort   by:  
 Page size 
UnknownPhase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma.
Not available
S-EPMC6286160 | biostudies-literature
UnknownAcute motor axonal neuropathy after ipilimumab and nivolumab treatment in melanoma brain metastases: A case report and review of the literature.
Not available
S-EPMC8392782 | biostudies-literature
UnknownLeptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions.
Not available
S-EPMC10126834 | biostudies-literature
UnknownQuantitation of paclitaxel, and its 6-alpha-OH and 3-para-OH metabolites in human plasma by LC-MS/MS.
Not available
S-EPMC6548629 | biostudies-literature
UnknownComparative clinical benefits of systemic adjuvant therapy for paradigm solid tumors.
Not available
S-EPMC8555872 | biostudies-literature
UnknownGenomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.
Not available
S-EPMC9064946 | biostudies-literature
UnknownMelanoma Brain Metastases: Current Areas of Investigation and Future Directions.
Not available
S-EPMC5300745 | biostudies-literature
UnknownEfficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.
Not available
S-EPMC5070559 | biostudies-literature
UnknownA Multicenter Phase I Study Evaluating Dual PI3K and BRAF Inhibition with PX-866 and Vemurafenib in Patients with Advanced BRAF V600-Mutant Solid Tumors.
Not available
S-EPMC5754240 | biostudies-literature
UnknownDoxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial.
Not available
S-EPMC7771354 | biostudies-literature
Sort   by:  
 Page size